Form 8-K - Current report:
SEC Accession No. 0001171843-21-003344
Filing Date
2021-05-10
Accepted
2021-05-10 16:05:23
Documents
2
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_051021.htm 8-K 11238
2 PRESS RELEASE exh_991.htm EX-99.1 31425
  Complete submission text file 0001171843-21-003344.txt   43814
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39617 | Film No.: 21907062
SIC: 2836 Biological Products, (No Diagnostic Substances)